Isabella Vittimberga

Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study

Silvia Stacchiotti, Gian Paolo Dagrada, Roberta Sanfilippo et al. · Clinical Sarcoma Research · 2013 · 39 citations · Full text

Medicine, Oncology, Pathology +17

Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study

Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni et al. · The Oncologist · 2021 · 24 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study

Carmelo Tibaldi, Andrea Camerini, Marcello Tiseo et al. · British Journal of Cancer · 2018 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15

Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial

Orazio Caffo, Cinzia Ortega, Franco Nolè et al. · European Journal of Cancer · 2021 · 17 citations

Medicine, Oncology, Urology +16

Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study

Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni et al. · BMC Cancer · 2022 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17